Supplementary Materials from Therapeutic Potential of HSP90 Inhibition for Neurofibromatosis Type 2
Karo Tanaka, Marco Giovannini(University of California, Los Angeles)
Cited by 0
Related Papers
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
|Genetics in Medicine|2021|766
Murine Nod1 but not its human orthologue mediates innate immune detection of tracheal cytotoxin
|EMBO Reports|2005|173
mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma
|Neuro-Oncology|2014|78